Down Syndrome Market Size and Share, Epidemiology and Market Research Report 2030 by DelveInsight

Down Syndrome Market Size and Share, Epidemiology and Market Research Report 2030 by DelveInsight

DelveInsight Business Research LLP
DelveInsight’s “Down Syndrome (DS) – Market Insights, Epidemiology, and Market Forecast – 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology and the market trends of Down syndrome (DS) in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

DelveInsight launched a new report on Down Syndrome (DS) Market Insights, Epidemiology, and Market Forecast 2030.

Down Syndrome (DS) is a genetic disorder caused by the presence of an extra copy of chromosome 21 making a total of 47 chromosomes instead of 46. The condition is associated with intellectual disability, a characteristic facial appearance, and weak muscle tone (hypotonia) in infancy.

DelveInsight’s “Down Syndrome (DS) Market Report 2030” delivers an in-depth understanding of the historical and forecasted epidemiology and the market trends of Down syndrome (DS) in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The total diagnosed prevalent population of Down syndrome (DS) in 7MM countries was estimated to be 699,750 cases in 2017.

Down Syndrome Key Pharma Players Involved:

  • ANVS-401 by Annovis Bio

Request for a free sample pages for the report: https://www.delveinsight.com/sample-request/down-syndrome-market

“The market size of Down syndrome in the seven major markets was found to be USD 662.9 million in 2017.”

Click here and get access to free sample pages of the report.

Table of contents:
1 Key Insight
2 Executive Summary of Down Syndrome
3 Down Syndrome Market Overview at a Glance
4 Disease Background and Overview: Down Syndrome
5 Case Reports
6 Down Syndrome Epidemiology and Patient Population
7 United States Epidemiology
8 EU5 Epidemiology
9 Japan Epidemiology
10 Current Down Syndrome Treatment and Medical Practices
11 Unmet needs
12 Down Syndrome Marketed Drugs
13 Down Syndrome Emerging Drugs
14 Down Syndrome 7MM Market Analysis
15 United States
16 EU-5 countries: Market Outlook
17 Japan Market Outlook
18 Down Syndrome Market Drivers
19 Down Syndrome Market Barriers
20 SWOT Analysis
21 Reimbursement and market access
22 Appendix
23 DelveInsight Capabilities
24 Disclaimer
25 About DelveInsight

Download our full report @https://www.delveinsight.com/sample-request/down-syndrome-market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/


Posted

in

by

Tags: